0001209191-19-047723.txt : 20190829 0001209191-19-047723.hdr.sgml : 20190829 20190829165951 ACCESSION NUMBER: 0001209191-19-047723 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190827 FILED AS OF DATE: 20190829 DATE AS OF CHANGE: 20190829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH WAYNE T CENTRAL INDEX KEY: 0001018660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15925 FILM NUMBER: 191067035 MAIL ADDRESS: STREET 1: 500 WEST MAIN STREET CITY: LOUISVILLE STATE: KY ZIP: 40202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC CENTRAL INDEX KEY: 0001108109 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 133893191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 MERIDIAN BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 615-465-7000 MAIL ADDRESS: STREET 1: 4000 MERIDIAN BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/ DATE OF NAME CHANGE: 20000229 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-27 0 0001108109 COMMUNITY HEALTH SYSTEMS INC CYH 0001018660 SMITH WAYNE T 4000 MERIDIAN BOULEVARD FRANKLIN TN 37067 1 1 0 0 Chairman & CEO Common Stock 2019-08-27 4 P 0 495600 1.84 A 3132082 D Common Stock 2019-08-28 4 P 0 489250 2.048 A 3621332 D Common Stock 2019-08-29 4 P 0 215150 2.178 A 3836482 D Common Stock 206842 I by 2009 WTS Irrevocable Trust Dated 2/27/09 Common Stock 481721 I WAC LLC Stock Options (Right to Buy) 30.32 2011-02-24 2020-02-23 Common Stock 50000 50000 D Stock Options (Right to Buy) 34.38 2012-02-23 2021-02-22 Common Stock 50000 50000 D Stock Options (Right to Buy) 17.49 2013-02-16 2022-02-15 Common Stock 40000 40000 D Stock Options (Right to Buy) 4.99 2020-03-01 2029-02-28 Common Stock 78750 78750 D Performance Based Restricted 0.00 Common Stock 75000 75000 D Performance Based Restricted 0.00 Common Stock 105000 105000 D Performance Based Restricted 0.00 Common Stock 157500 157500 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 8/27/2019 at prices ranging from $1.80 to $1.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1), (2) and (3) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 8/28/2019 at prices ranging from $1.87 to $2.14, inclusive. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 8/29/2019 at prices ranging from $2.12 to $2.20, inclusive. The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2017 and 12/31/2019 (the "2017-2019 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2017-2019 Performance Period. The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2018-2020 Performance Period. The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period. Christopher G. Cobb, Attorney in Fact for Wayne T. Smith 2019-08-29